Thursday, December 8, 2022
Home Tags NASDAQ: REGN

Tag: NASDAQ: REGN

Vyriad, Inc. Appoints Harry Hoffman to its Board of Directors

ROCHESTER, Minn., Aug. 24, 2021 (SEND2PRESS NEWSWIRE) -- Vyriad, Inc., a clinical-stage biotechnology company developing oncolytic virus therapies to treat a wide range of cancers, today announced the appointment of leading life sciences investor Harry Hoffman to the Company's board of directors.

FEATURED NEWS

NATIONAL NEWS